Oct 21, 2015

CardioCell Board Members and Clinical Trial Leads Collaborate On Peer-Reviewed Paper Published In The Journal Of Cardiovascular Medicine

CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, announces that collaboration between several scientific board members and principal investigators from its clinical trial sites resulted in a peer-reviewed publication now available in the Journal of Cardiovascular Medicine. READ FULL ARTICLE